267 related articles for article (PubMed ID: 24025098)
1. Imaging requirements for personalized medicine: the oncologists point of view.
Kruse V; Belle SV; Cocquyt V
Curr Pharm Des; 2014; 20(14):2234-49. PubMed ID: 24025098
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. PET-Based Personalized Management in Clinical Oncology: An Unavoidable Path for the Foreseeable Future.
Basu S; Alavi A
PET Clin; 2016 Jul; 11(3):203-7. PubMed ID: 27321025
[TBL] [Abstract][Full Text] [Related]
4. Functional MR Imaging Techniques in Oncology in the Era of Personalized Medicine.
Benz MR; Vargas HA; Sala E
Magn Reson Imaging Clin N Am; 2016 Feb; 24(1):1-10. PubMed ID: 26613872
[TBL] [Abstract][Full Text] [Related]
5. Molecular imaging of targeted therapies with positron emission tomography: the visualization of personalized cancer care.
Mammatas LH; Verheul HM; Hendrikse NH; Yaqub M; Lammertsma AA; Menke-van der Houven van Oordt CW
Cell Oncol (Dordr); 2015 Feb; 38(1):49-64. PubMed ID: 25248503
[TBL] [Abstract][Full Text] [Related]
6. Harnessing Preclinical Molecular Imaging to Inform Advances in Personalized Cancer Medicine.
Clark PM; Ebiana VA; Gosa L; Cloughesy TF; Nathanson DA
J Nucl Med; 2017 May; 58(5):689-696. PubMed ID: 28385796
[TBL] [Abstract][Full Text] [Related]
7. New PET radiopharmaceuticals beyond FDG for brain tumor imaging.
Gulyás B; Halldin C
Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):173-90. PubMed ID: 22617239
[TBL] [Abstract][Full Text] [Related]
8. PET-Based Molecular Imaging in Designing Personalized Management Strategy in Gastroenteropancreatic Neuroendocrine Tumors.
Basu S; Ranade R; Ostwal V; Shrikhande SV
PET Clin; 2016 Jul; 11(3):233-41. PubMed ID: 27321028
[TBL] [Abstract][Full Text] [Related]
9. Translational molecular imaging for cancer.
Pomper MG
Cancer Imaging; 2005 Nov; 5 Spec No A(Spec No A):S16-26. PubMed ID: 16361132
[TBL] [Abstract][Full Text] [Related]
10. Correlating and Combining Genomic and Proteomic Assessment with In Vivo Molecular Functional Imaging: Will This Be the Future Roadmap for Personalized Cancer Management?
Basu B; Basu S
Cancer Biother Radiopharm; 2016 Apr; 31(3):75-84. PubMed ID: 27093341
[TBL] [Abstract][Full Text] [Related]
11. Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone.
Talbot JN; Gligorov J; Nataf V; Montravers F; Huchet V; Michaud L; Ohnona J; Balogova S; Cussenot O; Daraï E; Lotz JP; Kerrou K
Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):4-17. PubMed ID: 25693420
[TBL] [Abstract][Full Text] [Related]
12. PET and PET/CT in pediatric oncology.
Jadvar H; Connolly LP; Fahey FH; Shulkin BL
Semin Nucl Med; 2007 Sep; 37(5):316-31. PubMed ID: 17707239
[TBL] [Abstract][Full Text] [Related]
13. The Rise of Radiomics and Implications for Oncologic Management.
Verma V; Simone CB; Krishnan S; Lin SH; Yang J; Hahn SM
J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 28423406
[TBL] [Abstract][Full Text] [Related]
14. Imaging of Tumor Characteristics and Molecular Pathways With PET: Developments Over the Last Decade Toward Personalized Cancer Therapy.
Marcu LG; Moghaddasi L; Bezak E
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1165-1182. PubMed ID: 29907486
[TBL] [Abstract][Full Text] [Related]
15. The Current and Evolving Role of PET in Personalized Management of Lung Cancer.
Mena E; Yanamadala A; Cheng G; Subramaniam RM
PET Clin; 2016 Jul; 11(3):243-59. PubMed ID: 27321029
[TBL] [Abstract][Full Text] [Related]
16. Imaging of Tumor Metabolism Using Positron Emission Tomography (PET).
Apostolova I; Wedel F; Brenner W
Recent Results Cancer Res; 2016; 207():177-205. PubMed ID: 27557539
[TBL] [Abstract][Full Text] [Related]
17. Molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging.
Schiepers C; Dahlbom M
Eur Radiol; 2011 Mar; 21(3):548-54. PubMed ID: 21174096
[TBL] [Abstract][Full Text] [Related]
18. Designing and Developing PET-Based Precision Model in Thyroid Carcinoma: The Potential Avenues for a Personalized Clinical Care.
Basu S; Parghane RV
PET Clin; 2017 Jan; 12(1):27-37. PubMed ID: 27863564
[TBL] [Abstract][Full Text] [Related]
19. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
20. Oncologic imaging: a guiding hand of personalized cancer care.
Hricak H
Radiology; 2011 Jun; 259(3):633-40. PubMed ID: 21493796
[No Abstract] [Full Text] [Related]
[Next] [New Search]
